MedTrace Logo

Koning Breast Computed Tomography Guided Neoadjuvant Treatment Monitoring

NCT01771497 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2016-01-13

No results posted yet for this study

Summary

The hypothesis of this study is that using Koning Breast CT during the neoadjuvant treatment of breast cancer will allow for accurate tumor localization and tumor volume measurement, leading to improved surgical and radiation therapy outcomes.

Conditions

Interventions

DEVICE

Koning Breast CT

Koning Breast CT scans will be assessed at the beginning, mid-point and end of therapy.

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • Koning Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01771497 on ClinicalTrials.gov